CORFF Cordlife Ltd featured news, full reports, and detailed charts
Cordlife Ltd (CORFF/CORFF.PK) Wrap Up:
Cordlife Limited operates a network of cord blood banks in Australia and Asia. It collects, processes, and stores cord blood stem cells for future use in lifesaving treatments. The company was founded in 2001 and is based in Melbourne, Australia.Cordlife Ltd (CORFF:Pink OTC Markets Inc)
Snapshot of Cordlife Ltd (CORFF)
|
OPEN
$0.52
|
PREVIOUS CLOSE
$0.54
|
|
|
DAY HIGH
$0.55
|
DAY LOW
$0.52
|
|
|
52 WEEK HIGH
09/25/09 - $0.65
|
52 WEEK LOW
02/27/09 - $0.0050
|
|
|
MARKET CAP
51.4M
|
AVERAGE VOLUME 3 mo
7.6K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
93.4M
|
|
|
CORFF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CORFF Top Compensated Officers
Executives, Board Directors
Key developments for Cordlife Ltd (CORFF)
Cordlife Limited reported parent earnings results for the full year ended June 30, 2009. For the year, the company reported loss before income tax and net loss attributable to members of AUD 2,847,000 on revenue of AUD 118,000 compared to loss before income tax and net loss attributable to members of AUD 2,140,000 on revenue of AUD 382,000 for the previous year. Net cash used in operating activities was AUD 465,000 compared to AUD 683,000 for the previous year.
Cordlife Limited, Annual General Meeting, Nov 30, 2009, at 12:00 EAST-East Australian Standard GST. Location: Middletons Lawyers, Level 25, Rialto South Tower, 525 Collins Street, Melbourne,Australia. Agenda: To consider financial statements and reports; to consider election of Mark Ryan and Voiron Chor as directors; to consider re-election of Samuel Kong; to consider adoption of remuneration report; to consider issue of up to 500,000 performance rights to Mr. Steve Fang and Mr. Jereme Yee, Executive Director, under the Cordlife option and performance rights plan; to consider issue of up to 350,000 performance rights to Mr. Samuel Kong, Executive Director, under the Cordlife option and performance rights plan; to consider ratification of previous issue of ordinary shares; to ratify the placement of 14,008,251 fully paid ordinary shares in the capital of the company at $0.43 per share.
Cordlife Limited announced that Ms Seow Bao Shuen has resigned from the Board of Directors of the company with effect from 22 September 2009.
CORFF Competitors
| Company | Last | Change | |
| No competitor information is available for CORFF. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CORFF | Industry Range |
| Price/Earnings | 15.2x |
|
| Price/Sales | 2.7x |
|
| Price/Book | 1.2x |
|
| Price/Cash Flow | 17.2x |
|
| TEV/Sales | 2.6x |
|
|
CORFF |
||
CORFF transactions
| Type Date |
Target |
|
Private Placement
October 23, 2009 |
-- |
